AR064367A1 - Composiciones de diclorohidrato de azimilida - Google Patents

Composiciones de diclorohidrato de azimilida

Info

Publication number
AR064367A1
AR064367A1 ARP070105639A ARP070105639A AR064367A1 AR 064367 A1 AR064367 A1 AR 064367A1 AR P070105639 A ARP070105639 A AR P070105639A AR P070105639 A ARP070105639 A AR P070105639A AR 064367 A1 AR064367 A1 AR 064367A1
Authority
AR
Argentina
Prior art keywords
compositions
dichlorohidrate
azimilide
furanyl
piperazinyl
Prior art date
Application number
ARP070105639A
Other languages
English (en)
Inventor
Nancy Lee Redman-Furey
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of AR064367A1 publication Critical patent/AR064367A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Composiciones farmacéuticas de los solvatos y varias formas polimorficas de (E)-1-[[[5-(4-clorofenil)-2-furanilo]metilen]amino]-3-[4-(4-metil-1-piperazinil)butilo]-2,4-imidazolidinadiona diclorhidrato.
ARP070105639A 2006-12-15 2007-12-14 Composiciones de diclorohidrato de azimilida AR064367A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87505106P 2006-12-15 2006-12-15

Publications (1)

Publication Number Publication Date
AR064367A1 true AR064367A1 (es) 2009-04-01

Family

ID=39401118

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP070105639A AR064367A1 (es) 2006-12-15 2007-12-14 Composiciones de diclorohidrato de azimilida

Country Status (19)

Country Link
US (2) US20080182858A1 (es)
EP (1) EP2125791A2 (es)
JP (1) JP2010513264A (es)
KR (1) KR20090089416A (es)
CN (1) CN101558063A (es)
AR (1) AR064367A1 (es)
AU (1) AU2007331033A1 (es)
BR (1) BRPI0720265A2 (es)
CA (1) CA2672132A1 (es)
CL (1) CL2007003643A1 (es)
IL (1) IL198807A0 (es)
MA (1) MA30992B1 (es)
MX (1) MX2009006475A (es)
PE (1) PE20081481A1 (es)
RU (1) RU2009117558A (es)
SM (1) SMAP200900061A (es)
TW (1) TW200840578A (es)
WO (1) WO2008072190A2 (es)
ZA (1) ZA200903390B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2016256776B2 (en) * 2009-03-18 2018-04-12 Incarda Therapeutics, Inc. Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration
EP3552603A1 (en) 2009-03-18 2019-10-16 Incarda Therapeutics, Inc. Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration
AU2013248242B2 (en) * 2009-03-18 2016-08-18 Incarda Therapeutics, Inc Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration
CN101735203B (zh) * 2009-12-17 2012-05-23 天津药物研究院 盐酸阿齐利特的晶型ⅱ及其制备方法和用途
US10918798B2 (en) * 2015-11-27 2021-02-16 Sanofi-Aventis Deutschland Gmbh Medicament injection device
EP3411030A4 (en) 2016-02-01 2019-09-04 InCarda Therapeutics, Inc. COMBINING ELECTRONIC SURVEILLANCE WITH INHALATION PHARMACOLOGICAL THERAPY FOR MANAGING CARDIAC ARRHYTHMIAS WITH ATRIAL FIBRILLATION
EP3621616A4 (en) 2017-05-10 2021-01-13 InCarda Therapeutics, Inc. UNIT DOSE, AEROSOLS, KITS AND METHODS FOR TREATMENT OF HEART DISEASE BY PULMONAL ADMINISTRATION
WO2019183470A2 (en) 2018-03-22 2019-09-26 Incarda Therapeutics, Inc. A novel method to slow ventricular rate
US11007185B2 (en) 2019-08-01 2021-05-18 Incarda Therapeutics, Inc. Antiarrhythmic formulation
CN113861164B (zh) * 2021-10-29 2022-09-20 迪嘉药业集团有限公司 一种烟碱的结晶制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4032645A (en) * 1975-06-19 1977-06-28 G. D. Searle & Co. Injectable metronidazole composition
HU221317B1 (en) * 1991-08-14 2002-09-28 Procter & Gamble Pharma 2,4-imidazolidinedione derivatives and antiarrhythmic and antifibrillatory compositions containing them, and process for producing them
JP4514950B2 (ja) * 1998-04-29 2010-07-28 ザ プロクター アンド ギャンブル カンパニー １，３−二置換−４−オキソ環式尿素の製造方法
WO1999055700A1 (en) * 1998-04-29 1999-11-04 The Procter & Gamble Company Process for making 1,3-disubstituted-4-oxocyclic ureas
US7060712B2 (en) * 2003-05-08 2006-06-13 Theravance, Inc. Crystalline form of aryl aniline β2 adrenergic receptor agonist

Also Published As

Publication number Publication date
CA2672132A1 (en) 2008-06-19
US20080182858A1 (en) 2008-07-31
JP2010513264A (ja) 2010-04-30
IL198807A0 (en) 2010-02-17
BRPI0720265A2 (pt) 2014-01-28
EP2125791A2 (en) 2009-12-02
WO2008072190A2 (en) 2008-06-19
RU2009117558A (ru) 2011-01-20
WO2008072190A3 (en) 2008-11-06
CN101558063A (zh) 2009-10-14
MA30992B1 (fr) 2009-12-01
AU2007331033A1 (en) 2008-06-19
CL2007003643A1 (es) 2008-03-24
TW200840578A (en) 2008-10-16
SMAP200900061A (it) 2009-09-07
ZA200903390B (en) 2010-04-28
US20110237603A1 (en) 2011-09-29
PE20081481A1 (es) 2008-11-07
KR20090089416A (ko) 2009-08-21
MX2009006475A (es) 2009-06-26

Similar Documents

Publication Publication Date Title
AR064367A1 (es) Composiciones de diclorohidrato de azimilida
DK2152486T3 (da) Blæsestøbt pose-i-beholder i ét stykke, der omfatter et indvendigt lag og et udvendigt lag, der indeholder energiabsorberende tilsætningsstoffer, forform til fremstilling af denne og anvendelse
AR102756A2 (es) Formas polimórficas de 3-(4-amino-1-oxo-1,3-dihidro-isoindol-2-il)-piperidin-2,6-diona y composiciones que las comprenden
EA201001359A1 (ru) Гетероциклические соединения в качестве ингибиторов cxcr2
CL2007003459A1 (es) Proceso de preparacion de compuestos derivados de pirimidina; y compuesto intermediario (s)-trans-etil 3-etoxi-7-(4-(4-fluorofenil)-6-isopropil-2-(n-metilmetilsulfonamido)pirimidin-5-il)-5-hidroxihep-2,6-dienoato.
WO2006034093A3 (en) 3- (2-acylamino-1-hydroxyethyl)- morpholine derivatives and their use as bace inhibitors
CL2011001333A1 (es) Compuestos derivados de heterociclos nitrogenados sustituidos, inhibidores de ns5a; composicion farmaceutica; y su uso para el tratamiento de la hepatitis c.
DK1751131T3 (da) MTP-inhiberende arylpiperidiner eller -piperaziner, der er substitueret med 5-leddede heterocykler
BRPI0808172A2 (pt) Compostos heterocíclicos, composições compreendendo-os e métodos de seu uso.
ATE547415T1 (de) Inhibitoren der wechselwirkung zwischen mdm2 und p53
RS53196B (en) INHIBITORI POLI (ADP-RIBOZA) POLIMERAZE
ECSP034859A (es) Nuevos derivados de pirrol como agentes farmacéuticos
BR112012008385A2 (pt) inibidores de p13 cinase e uso dos mesmos.
BRPI0920598A2 (pt) formas sólidas de n-(4(7-azabiciclo[2.2.1]heptan-7-il)-2-(triflúor-metil)fenil)-4-oxo-5-(triflúor-metil)-1,4-di-hidroquinolina-3-carboxamida
ATE470665T1 (de) Cycloalkylaminderivate als inhibitoren der wechselwirkung zwischen mdm2 und p53
DK1353917T3 (da) Ny fremgangsmåde til syntesen af 5-(4-fluorphenyl)-1-[2-((2R,4R)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1H-pyrrol-3-carboxylsyre phenylamid
WO2007062399A3 (en) Oncogenic ras-specific cytotoxic compound and methods of use thereof
WO2011053938A8 (en) Methods and compositions for treating cancer
BRPI0908097A2 (pt) uso de pelo menos um composto, peptídeo, e, formulação farmacêutica.
CL2012002382A1 (es) Combinaciones fungicidas que consisten de tebuconazol, axistrobina y fludioxonil, y uno o más auxiliares de formulación habituales (div. sol. 1791-07).
BRPI0813341A2 (pt) " uso de compostos, composições curáveis, e, uso de composições curáveis ".
CY1113409T1 (el) Αναστολεις ακτ και ρ70 s6 κινασης
ATE553104T1 (de) Substituierte 1h-benzimidazol-4-carboxamide als potente parp-hemmer
BRPI0815048A2 (pt) derivado de fenóxi-pirrolidinas e uso e composições do mesmo
DK1713801T3 (da) Fremgangsmåde til fremstilling af 1-(2S,3S)-2-benzhydryl-N-(5-tert-butyl-2-methoxybenzyl)quinuclidin-3-amin

Legal Events

Date Code Title Description
FA Abandonment or withdrawal